Mar 24, 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Posted by Nicholi Avery in categories: biotech/medical, health
SARS-CoV-2 uses the SARS-CoV receptor ACE2 for host cell entry.
The spike protein of SARS-CoV-2 is primed by TMPRSS2.
Antibodies against SARS-CoV spike may offer some protection against SARS-CoV-2.